Reuben Pharmaceuticals Private Limited
About Reuben Pharmaceuticals Private Limited
Data last updated:
Reuben Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 28 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2007PTC161194. Its GSTIN is 07AADCR8825Q1ZM (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anirudh Lochan and Rajeev Lochan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4 Saini Enclave New Delhi, Delhi, India – 110062.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.22 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹2.21 Lakh (net margin 1.8%) and EBITDA of ₹2.49 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Reuben Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address4 Saini Enclave New Delhi, Delhi, India – 110062
- IndustryHealthcare, Human Health Activities
To see the full contact details of Reuben Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Reuben Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Reuben Pharmaceuticals Private Limited, buy the company report.
Financials of Reuben Pharmaceuticals Private Limited
FY 2025 filings availableReuben Pharmaceuticals Private Limited reported revenue of ₹1.22 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 6% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reuben Pharmaceuticals Private Limited, buy the company report.
Board of directors of Reuben Pharmaceuticals Private Limited
Reuben Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anirudh Lochan Also directs: Ural Health Care Private Limited | Director | 19 Jan 2012 | 14 Years 9 Months | Current |
| Rajeev Lochan | Director | 28 Mar 2007 | 19 Years 7 Months | Current |
| Usha Rani | Director | 28 Mar 2007 | 19 Years 7 Months | Current |
Peer comparison
Reuben Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aavhanzr Pharmaceuticals Private Limited | ₹1.22 Cr (FY 2025) | -18.0% | Bangalore, Karnataka, India | |||
| Reuben Pharmaceuticals Private Limitedthis company | ₹1.22 Cr (FY 2025) | ₹2.21 Lakh | 1.8% | 6.0% | New Delhi, Delhi, India | |
| Sandal India Pharmaceuticals Private Limited | ₹1.21 Cr (FY 2025) | -2.0% | Muzaffarpur, Bihar, India | |||
| Care Bridge Pharmaceuticals Private Limited | ₹1.21 Cr (FY 2025) | 39.0% | Sri Ganganagar, Rajasthan, India | |||
| Milus Pharmaceuticals Private Limited | ₹1.21 Cr (FY 2024) | 228.0% | Mumbai, Maharashtra, India | |||
| Herumb Pharmaceuticals and Chemical Private Limited | ₹1.21 Cr (FY 2024) | 1886.0% | Rajkot, Gujarat, India |
To see the full peer comparison of Reuben Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Reuben Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reuben Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Reuben Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCR8825Q1ZM | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Reuben Pharmaceuticals Private Limited, buy the company report.
Recent activity
Reuben Pharmaceuticals Private Limited has 6 board changes on record since 2007: 3 appointments and 3 cessations. The latest: Anirudh Lochan was appointed as Director on 19 Jan 2012.
Frequently asked questions
Reuben Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in human health activities, within the healthcare industry. It was incorporated on 28 March 2007 (19+ years old) and is registered under CIN U85100DL2007PTC161194.
Reuben Pharmaceuticals has 3 current directors:
- Anirudh Lochan - Director
- Rajeev Lochan - Director
- Usha Rani - Director
The latest financial statements of Reuben Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Reuben Pharmaceuticals is 07AADCR8825Q1ZM, registered in Delhi.
The CIN (Corporate Identification Number) of Reuben Pharmaceuticals is U85100DL2007PTC161194. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reuben Pharmaceuticals was incorporated on 28 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Reuben Pharmaceuticals by revenue are Aavhanzr Pharmaceuticals Private Limited, Sandal India Pharmaceuticals Private Limited, Care Bridge Pharmaceuticals Private Limited, Milus Pharmaceuticals Private Limited, Herumb Pharmaceuticals and Chemical Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anirudh Lochan was appointed as Director on 19 Jan 2012. Mahesh Chand Sharma ceased to be Director on 12 Nov 2011. Rajesh Kumar Sharma ceased to be Director on 12 Nov 2011. Reuben Pharmaceuticals has 6 board changes on record in total.
The registered office of Reuben Pharmaceuticals is at 4 Saini Enclave New Delhi, Delhi, India – 110062.
Reuben Pharmaceuticals operates in the healthcare industry, in the human health activities segment.
The compliance status of Reuben Pharmaceuticals is compliant as of 02 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
